Mindfulness Therapy in Inflammatory Bowel Disease
- Conditions
- Bowel Disease
- Interventions
- Behavioral: Mindfulness
- Registration Number
- NCT02963246
- Lead Sponsor
- Cardenal Herrera University
- Brief Summary
Aim: To compare the effects of a specific application of Mindfulness vs. Treatment-asusual control group in patients with bowel disease. Design: randomized controlled trial. Setting: Outpatient setting. Population: patients who attended bimonthly check up.
- Detailed Description
Background: Inflammatory bowel disease (IBD) is a chronic gastrointestinal condition with a relapsing disease course. Managing the relapsing nature of the disease causes daily stress for IBD patients. Mindfulness-based Cognitive Therapy (MBCT) is an evidence-based psychological program designed to help manage depressive and stress symptoms.
Aim: To compare the effects of a specific application of Mindfulness vs. Treatment-as usual control group in patients with bowel disease.
Outcome measures: quality of life, inflammatory and stress markers. Design: randomized controlled trial. Setting: Outpatient setting. Population: patients who attended bimonthly check up.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
- patients with bowel disease diagnostic
- patients with non active disease symptoms in the last 3 month
- patients with access to internet and basic informatic knowledge
- active disease symptoms
- planned surgery
- cognitive impairment
- previous experience with mindfulness
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mindfulness group Mindfulness Mindfulness intervention (12 months). Mindfulness based Cognitive Therapy is an evidence-based psychological program designed to help manage depressive and stress symptoms.
- Primary Outcome Measures
Name Time Method Quality of life measured with the IBDQ-32 (Inflammatory Bowel Disease Questionnaire) Change from Baseline IBDQ-32 score at 12 months
- Secondary Outcome Measures
Name Time Method inflammation stress markers (reactive Protein C and faecal calprotectin) Change from Baseline inflammation stress markers at 12 months
Trial Locations
- Locations (1)
Universidad CEU Cardenal Herrera
🇪🇸Elche, Spain